Acotec Scientific Holdings Limited provided revenue guidance for the year ended December 31, 2021. For the period the Group expects to record: revenue of approximately RMB 300 million to RMB 303 million, representing an increase of approximately 54.7% to 56.2% as compared to that of the year ended December 31, 2020.
Acotec Scientific Holdings Limited
Equities
6669
KYG0096M1096
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.9 HKD | +3.81% | +8.52% | -29.96% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.96% | 30Cr | |
+75.69% | 1.26TCr | |
-24.12% | 728.94Cr | |
+10.90% | 680.82Cr | |
+20.88% | 566.86Cr | |
-16.83% | 491.45Cr | |
+19.43% | 418.21Cr | |
-19.59% | 386.19Cr | |
-24.00% | 292.38Cr | |
+52.88% | 257.08Cr |
- Stock Market
- Equities
- 6669 Stock
- News Acotec Scientific Holdings Limited
- Acotec Scientific Holdings Limited Provides Revenue Guidance for the Year Ended December 31, 2021